FLERIE Flerie AB (publ)
Flerie AB (publ) is a venture capital firm specializing in early-stage investments. The firm seeks to invest in life science, biotech and pharma companies engaged in drug development and associated tools or applications tackling major medical challenges of our time. The firm seeks to invest in Europe, Nordic, United States and Israel. Flerie AB (publ) was founded in 2011 and is based in Stockholm, Sweden with additional office in London, United Kingdom.…
Industry Peers
BiotechnologyKey Statistics
About Flerie (STO: FLERIE)
›
Flerie (STO: FLERIE) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Biotechnology industry, part of the Healthcare sector, and reports about 8 employees.
The shares were at 12.40 SEK on 20 November 2026, down 63.1% over 52 weeks. Its 52-week range is 12.30 SEK to 35.13 SEK, and it trades at the bottom of that range.
Its market capitalisation is 1.11B SEK.
Flerie reports return on equity of -22.4% and flat revenue year over year.
It holds more cash than debt, a net cash position of 263.50M SEK. Its Piotroski F-score is 2 out of 9, a weak reading of its financial health. One analyst covers the stock; their mean price target of 22.00 SEK is 77.4% above the current price.